White Paper

Understanding The CMC Regulatory Landscape For Cell And Gene Therapy Products

Source: Thermo Fisher Scientific

By Monica M. Commerford, Ph.D., Manager, Regulatory Affairs, Thermo Fisher Scientific

Virus Cell

Cell and gene therapies can dramatically impact patients’ lives by providing a cure for a disease rather than a long-term treatment. In addition, many of these products are targeting rare diseases, leading to an increase in molecules following expedited approval pathways. These factors are driving the industry’s passion and motivation to gain a better understanding of the evolving regulatory guidelines for cell and gene therapies, in order to bring them to market faster. However, collaboration and communication between the industry and regulators is needed to commercialize these products without sacrificing quality.

VIEW THE WHITE PAPER!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Pharmaceutical Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: